Equities research analysts predict that Medical Properties Trust, Inc. (NYSE:MPW) will post sales of $171.72 million for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for Medical Properties Trust’s earnings, with estimates ranging from $166.81 million to $175.36 million. Medical Properties Trust posted sales of $126.56 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 35.7%. The firm is scheduled to announce its next quarterly earnings results on Thursday, November 2nd.
On average, analysts expect that Medical Properties Trust will report full year sales of $171.72 million for the current year, with estimates ranging from $681.10 million to $695.07 million. For the next year, analysts anticipate that the business will post sales of $826.95 million per share, with estimates ranging from $785.91 million to $850.22 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Medical Properties Trust.
Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings data on Wednesday, August 9th. The real estate investment trust reported $0.32 earnings per share for the quarter, meeting the consensus estimate of $0.32. Medical Properties Trust had a return on equity of 7.54% and a net margin of 42.25%. The business had revenue of $166.80 million for the quarter, compared to analysts’ expectations of $163.08 million. During the same period last year, the business earned $0.32 EPS. The business’s revenue was up 32.1% on a year-over-year basis.
A number of equities research analysts have recently commented on the company. ValuEngine raised Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. KeyCorp reissued a “hold” rating on shares of Medical Properties Trust in a research note on Sunday, September 17th. Jefferies Group LLC reissued a “buy” rating and issued a $15.00 target price on shares of Medical Properties Trust in a research note on Tuesday, August 29th. Zacks Investment Research cut Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Wednesday, August 2nd. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $13.00 target price on shares of Medical Properties Trust in a research note on Friday, July 28th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $14.10.
COPYRIGHT VIOLATION NOTICE: This piece was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another site, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/2956221/171-72-million-in-sales-expected-for-medical-properties-trust-inc-mpw-this-quarter.html.
Several large investors have recently made changes to their positions in the company. WFG Advisors LP lifted its holdings in shares of Medical Properties Trust by 14.9% during the second quarter. WFG Advisors LP now owns 304,369 shares of the real estate investment trust’s stock valued at $3,917,000 after purchasing an additional 39,565 shares in the last quarter. Cetera Investment Advisers bought a new position in shares of Medical Properties Trust during the second quarter valued at $141,000. Public Employees Retirement System of Ohio lifted its holdings in shares of Medical Properties Trust by 386.2% during the second quarter. Public Employees Retirement System of Ohio now owns 168,636 shares of the real estate investment trust’s stock valued at $2,170,000 after purchasing an additional 133,955 shares in the last quarter. Verition Fund Management LLC lifted its holdings in shares of Medical Properties Trust by 62.5% during the second quarter. Verition Fund Management LLC now owns 42,076 shares of the real estate investment trust’s stock valued at $542,000 after purchasing an additional 16,176 shares in the last quarter. Finally, National Asset Management Inc. bought a new position in shares of Medical Properties Trust during the second quarter valued at $148,000. 83.69% of the stock is currently owned by hedge funds and other institutional investors.
Medical Properties Trust (NYSE:MPW) opened at 13.12 on Friday. The company has a market capitalization of $4.59 billion, a PE ratio of 16.04 and a beta of 0.88. The firm’s 50-day moving average price is $13.09 and its 200 day moving average price is $13.09. Medical Properties Trust has a 52 week low of $11.54 and a 52 week high of $15.04.
The firm also recently declared a quarterly dividend, which was paid on Thursday, October 12th. Stockholders of record on Thursday, September 14th were issued a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.32%. The ex-dividend date of this dividend was Wednesday, September 13th. Medical Properties Trust’s payout ratio is currently 115.66%.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.